Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study

BACKGROUND: To determine the impact of dipeptidyl peptidase-4 inhibitor (DPP4i) on the risk of major cardiocerebrovascular and renal outcomes compared with sulfonylurea (SU) combined with metformin in patients with type 2 diabetes from a population-based cohort. METHODS: From a nationwide cohort in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyoung Jin, Choi, Jimi, Lee, Juneyoung, Bae, Jae Hyun, An, Jee Hyun, Kim, Hee Young, Yoo, Hye Jin, Seo, Ji A., Kim, Nan Hee, Choi, Kyung Mook, Baik, Sei Hyun, Kim, Sin Gon, Kim, Nam Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410523/
https://www.ncbi.nlm.nih.gov/pubmed/30857540
http://dx.doi.org/10.1186/s12933-019-0835-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410523/
https://www.ncbi.nlm.nih.gov/pubmed/30857540
http://dx.doi.org/10.1186/s12933-019-0835-z

Ejemplares similares